China to Accelerate Innovations in Chronic Disease Management

26 October 2021 | Tuesday | News

111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced a strategic cooperation agreement with Chugai Pharma China Co., Ltd. ("Chugai Pharma China").
Image Source : Public Domain

Image Source : Public Domain

The agreement will allow 111 and Chugai Pharma China to work together towards building a "Healthy China" by establishing a "SMART Healthcare City" concept through the use of digital drug distribution programs, and expanding the accessibility of treatment programs with modern logistics.

Currently, 111 is the first e-commerce company in China to have the omni-channel commercialization partnership with Chugai Pharma China. These initiatives will provide patients with end-to-end innovative medical solutions and strengthen the comprehensive management of chronic diseases. 111 will leverage its advantages in Internet technology, intelligent supply chain, omni-channel drug commercialization and cloud service e-commerce, combined with Chugai Pharma China's extensive international experience, professional knowledge, and innovative medical solutions in the treatment of various diseases, to develop and implement a national medicine and Internet strategy.

Present at the signing ceremony were Dr. YU Gang, Co-founder & Executive Chairman of 111, Yukimatsu Kunihiko, Chairman and General Manager of Chugai Pharma China, as well as members of the media and over 50 representatives from medical institutions, industry associations and pharmaceutical companies.

Mr. Yukimatsu stated, "The 'Healthy China 2030' plan proposed by the Chinese government aims to provide equal access to quality healthcare to the public by 2030. In order to achieve this goal, chronic disease management will be a key factor for the entire healthcare system. This new strategic partnership with 111 will enable us to help answer that call. I am deeply honored and firmly believe that this collaboration will be beneficial for bringing new, convenient and accessible medical solutions to more Chinese patients and their families."

"We are excited about this new partnership with Chugai Pharma China," commented Dr. Yu. "Its extensive knowledge and wealth of international experience will serve as significant assets as we work to achieve our mutual goal of providing patients with a full range of healthcare solutions. As we move forward in this partnership, 111 will be able to provide a variety of resources, technology and platform support for Chugai Pharma China. Together, both enterprises will collaborate and share resources to bring more convenient medical services to patients with chronic diseases in China."

Professor ZHANG Junfeng, Director of cardiovascular department of Shanghai Ninth People's Hospital, JiaoTong University School of Medicine stated, "This partnership will allow cardiovascular patients to conveniently access educational materials regarding their diseases, treatment options, and effective disease management tools. This will improve the patients' quality of life, reduce costs, and provide doctors with additional tools to better help their patients. "


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in